To further generate laboratory evidence for the above data analysis, we measured the expression levels of IFI30 in four existing GBM cells and displayed the highest expression of IFI30 in SW1783 cells, which were selected for the subsequent mRNA knockdown assay (Figure 8A). The gene discussed is IFI30; the disease is glioblastoma.